KRAS and cancer: Interestingly, VCAN and IKBKB alterations (mostly missense mutations) each occur in 5% of all cancer patients and are significantly mutually enriched (VCAN in KRAS and IKBKB in VCAN mutations) suggesting mutual addiction (Figure S16A–C).